Evaluation of encapsulated Newcastle disease virus liposomes using various phospholipids administered to improve chicken humoral immunity

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 91, Issue 2, 2009, Pages 621-625

  Tseng, Li Ping ^a   Chiou, Chwei Jang ^b   Deng, Ming Chung ^c   Lin, Mei Hsiu ^b   Pan, Ryh Nan ^d   Huang, Yi You ^a   Liu, Der Zen ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c FISHERIES RESEARCH INSTITUTE   (Taiwan)

^d Taiwan Police College   (Taiwan)

Author keywords

Adjuvant; Intranasal delivery; Liposomal vaccine; Newcastle disease virus

Indexed keywords

ADJUVANT; ANTIBODY PRODUCTION; ANTIBODY TITERS; ANTIGEN DELIVERY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNE RESPONSE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INTRANASAL; INTRANASAL DELIVERY; LIPOSOMAL VACCINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID LIPOSOMES;

ANTIBODIES; ANTIGENS; BODY FLUIDS; DYES; ENZYME INHIBITION; IMMUNOLOGY; PHOSPHOLIPIDS; SIMULATED ANNEALING; VACCINES;

LIPOSOMES;

CHOLESTEROL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPOSOME; NEWCASTLE DISEASE VACCINE; NEWCASTLE DISEASE VIRUS LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CHICKEN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; DRUG CARRIERS; DRUG COMPOUNDING; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXCIPIENTS; HEMAGGLUTINATION INHIBITION TESTS; IMMUNITY, HUMORAL; IMMUNIZATION; IMMUNOGLOBULIN G; LIPOSOMES; NEWCASTLE DISEASE VIRUS; PARTICLE SIZE; PHOSPHOLIPIDS; TRACHEA; VIRAL VACCINES;

EID: 71649100288     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31437     Document Type: Article

References (25)

1. Gregoriadis G. Immunological adjuvants: A role for liposomes. Immunol Today 1990;11:89-97.
2. Van Rooijen N. Liposomes as carriers and immuoadjuvant of vaccine antigens. In: Mizrahi A, editor. Bacterial Vaccines. New York: Alan R. Liss; 1996. pp 256-279.
3. Abraham E. Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response. Vaccine 1992;10: 461-488.
4. de Jonge MI, Hamstra HJ, Jiskoot W, Roholl P, Williams NA, Dankert J, van Alphen L, van der Ley P. Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins. Vaccine 2004; 22:4021-4028. (Pubitemid 39208766)
5. Childers NK, Miller KL, Tong G, Llarena JC, Greenway T, Ulrich JT, Michalek SM. Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen. Infect Immun 2000;68:5509-5516. (Pubitemid 30739327)
6. Miller CR, Bondurant B, McLean SD, McGovern KA, O'Brien DF. Liposome-cell interactions in vitro: Effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. Biochemistry 1998;37:12875-12883. (Pubitemid 28433520)
7. Yasuda T, Dancey GF, Kinsky SC. Immunogenicity of liposomal model membranes in mice: Dependence on phospholipid composition. Proc Natl Acad Sci USA 1977;74:1234-1236. (Pubitemid 8065640)
8. Yotsumoto S, Kakiuchi T, Aramaki Y. Enhancement of IFN-gamma production for Th1-cell therapy using negatively charged liposomes containing phosphatidylserine. Vaccine 2007;25:5256-5262. (Pubitemid 46977545)
9. Nakanishi T, Kunisawa J, Hayashi A, Tsutsumi Y, Kubo K, Nakagawa S, Fujiwara H, Hamaoka T, Mayumi T. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem Biophys Res Commun 1997;240:793-797. (Pubitemid 28271799)
10. Aramaki Y, Akiyama K, Hara T, Tsuchiya S. Recognition of charged liposomes by rat peritoneal and splenic macrophages: Effects of fibronectin on the uptake of charged liposomes. Eur J Pharm Sci 1995;3:63-70.
11. Aldous EW, Alexander DJ. Detection and differentiation of Newcastle disease virus (avian paramyxoviruses type 1). Avian Pathol 2001;30:117-128. (Pubitemid 32453798)
12. Beard CW, Hanson RP. Newcastle disease. In: Hofstad MS, Barnes HJ, Calnek BW, Reid WM, Yoder HW, editors. Diseases of Poultry,8th ed. Ames, IO: Iowa State University Press; 1984. pp 452-470.
13. Alexander DJ, Jones RC. Paramyxoviridae. In: Jordan FTW, Pattison M, Alexander DJ, Faragher T, editors. Poultry Diseases, 5th ed. London: W.B. Saunders; 2001. pp 257-272.
14. Alexander DJ. Newcastle disease. In: Saif YM, Barnes HJ, Glisson JR, Fadly AM, McDougald LR, Swayne DE, editors. Diseases of Poultry,11th ed. Ames, IO: Iowa State University Press; 2003. pp 64-87.
15. Lin YM, Liu DZ, Hawand HM, Tseng LP. Measurement of the second virial coefficient of DPPC and DPPG liposomes by isothermal titration calorimetry. J Chin Inst Chem Eng 2007;38:103-106.
16. Tseng LP, Liang HJ, Liu DZ. Liposomes incorporated with cholesterol for drug release triggered by magnetic field. J Med Biol Eng 2007;27:29-34. (Pubitemid 46724808)
17. Alving CR. Immunologic aspects of liposomes: Presentation and processing of liposomal protein and phospholipid antigens. Biochim Biophys Acta 1992;113:307-322.
18. Mazumdar T, Anam K, Ali N. Influence of phospholipid composition on the adjuvanticity and protective efficacy of liposome- encapsulated Leishmania donovani antigens. J Parasitol 2005;91:269-274. (Pubitemid 40756261)
19. Fatunmbi OO, Newman JA, Sivanandan V, Halvorson DA. Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant. Vaccine 1992;10:623-626.
20. Iwaoka S, Nakamura T, Takano S, Tsuchiya S, Aramaki Y. Cationic liposomes induce apoptosis through p38 MAP kinase- caspase-8-Bid pathway in macrophage-like RAW264.7 cells. J Leukoc Biol 2006;79:184-191. (Pubitemid 43054264)
21. Kuo JH, Jan MS, Chang CH, Chiu HW, Li CT. Cytotoxicity characterization of catanionic vesicles in RAW 264.7 murine macrophage-like cells. Colloids Surf B Biointerfaces 2005;41:189-196.
22. Henry F, Boisteau O, Bretaudeau L, Lieubeau B, Meflah K, Grégoire M. Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines. Cancer Res 1999;59:3329-3332. (Pubitemid 29334486)
23. Kawasaki Y, Nakagawa A, Nagaosa K, Shiratsuchi A, Nakanishi Y. Phosphatidylserine binding of class B scavenger receptor type I, a phagocytosis receptor of testicular sertoli cells. J Biol Chem 2002;277:27559-32766
24. Phillips NC, Gagné L, Ivanoff N, Riveau G. Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. Vaccine 1996;14:898-904. (Pubitemid 26280931)
25. Aramaki Y, Nitta F, Matsuno R, Morimura Y, Tsuchiya S. Inhibitory effects of negatively charged liposomes on nitric oxide production from macrophages stimulated by LPS. Biochem Biophys Res Commun 1996;220:1-6. (Pubitemid 26106789)